+ Watch XOMA
on My Watchlist
A biopharmaceutical company that discovers, develops and manufactures antibodies and other genetically-engineered protein products to treat immunological and inflammatory disorders, cancer and infectious diseases.
Calling BS on this one. It would be great if they could help cancer with recombinant whatever, but I think 9 out of 10 microcap companies in this space will go bankrupt.
Ya most will probably go bankrupt eventually. XOMA might. On the other hand this is not garage company praying for a make-or-break miracle drug to keep them afloat. They have had several legit successes that they are collecting royalties on from some of the bigger names. Would not recommend anyone buy these small cap biopharm stocks for a "safe" play. If you want to be speculative though and have a large upside potential this is a nice stock with a huge upside.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions